Pharmacologic Actions of the Second-Generation Leukotriene B4 Receptor Antagonist LY293111: In Vitro Studies by Jackson, William T., Froelich, Larry L., Boyd, Robert J., Schrementi, James P., Saussy, David L., Schultz, Richard M., Sawyer, J. Scott, Sofia, Michael J., Herron, David K., Goodson, Theodore, Snyder, David W., Pechous, Penni A., Spaethe, Stephen M., Roman, Carlos R., Fleisch, Jerome H.

Get full text

Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines by Hodson, Stephen J, Bigham, Eric C, Garrison, Deanna T, Gobel, Michael J, Irving, Paul E, Liacos, James A, Navas, 3rd, Frank, Saussy, Jr, David L, Sherman, Bryan W, Speake, Jason D, Bishop, Michael J

Get full text

2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues by Hodson, Stephen J, Bishop, Michael J, Speake, Jason D, Navas, 3rd, Frank, Garrison, Deanna T, Bigham, Eric C, Saussy, Jr, David L, Liacos, James A, Irving, Paul E, Gobel, M Jeffrey, Sherman, Bryan W

Get full text

Biphenylyl-substituted xanthones: highly potent leukotriene B4 receptor antagonists by Sawyer, J. Scott, Baldwin, Ronald F, Sofia, Michael J, Floreancig, Paul, Marder, Philip, Saussy, David L, Froelich, Larry L, Silbaugh, Steven A, Stengel, Peter W

Get full text